
    
      The specific aims of this study is to: (1) evaluate the antidepressant efficacy of rTMS on
      major depression; (2) evaluate the effects of rTMS on cognitive function in depressive
      patients; (3) assess the effects of rTMS on cerebral glucose metabolism in depressive
      patients as measured by 18FDG PET; (4) investigate the differences of the regional cerebral
      glucose uptake changes during rTMS between responders and nonresponders to rTMS.
    
  